ALEXANDRIA, Virginia, Feb. 18 -- SUZHOU ZANRONG PHARMA LIMITED, Suzhou, China has been assigned a patent (No. US 12226414 B2, initially filed Sept. 16, 2019) developed by Ding Zhou, Shanghai, China, and Ziqiang Cheng, Shanghai, China, for "1-isopropyl-3-methyl-8-(pyridin-3-yl)-1,3-dihydro-2H-imidazo[4,5-c] cinnolin-2-one as selective modulators of ataxia telangiectasia mutated (ATM) kinase and uses thereof." . . .